Abbott Laboratories (ABT)vsHaemonetics Corporation (HAE)
ABT
Abbott Laboratories
$105.64
+0.24%
HEALTHCARE · Cap: $177.07B
HAE
Haemonetics Corporation
$85.38
-1.62%
HEALTHCARE · Cap: $3.89B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 3392% more annual revenue ($46.59B vs $1.33B). ABT leads profitability with a 11.7% profit margin vs 7.3%. HAE appears more attractively valued with a PEG of 1.35. HAE earns a higher WallStSmart Score of 56/100 (C).
ABT
Buy52
out of 100
Grade: C-
HAE
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-46.2%
Fair Value
$73.35
Current Price
$105.64
$32.29 premium
Margin of Safety
+33.5%
Fair Value
$86.50
Current Price
$85.38
$1.12 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Earnings expanding 28.4% YoY
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Earnings declined 47.5%
4.8% revenue growth
Distress zone — elevated risk
7.3% margin — thin
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap. Revenue growth of 13.0% demonstrates continued momentum.
Bull Case : HAE
The strongest argument for HAE centers on EPS Growth. PEG of 1.35 suggests the stock is reasonably priced for its growth.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, EPS Growth.
Bear Case : HAE
The primary concerns for HAE are Revenue Growth, Altman Z-Score, Profit Margin. A P/E of 41.3x leaves little room for execution misses. Debt-to-equity of 1.54 is elevated, increasing financial risk.
Key Dynamics to Monitor
ABT carries more volatility with a beta of 0.61 — expect wider price swings.
ABT is growing revenue faster at 13.0% — sustainability is the question.
ABT generates stronger free cash flow (916M), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
HAE scores higher overall (56/100 vs 52/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Haemonetics Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?